JG
Jeremy Grantham (GMO) disclosed increased in NOVARTIS AG
Jeremy Grantham (GMO) filed a 13F change in NOVARTIS AG (66987V109) on 2026-05-14, covering period end 2026-03-31.
Action
Increased
Capital
$856,295 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.